Halozyme Therapeutics (NASDAQ:HALO) Target Raised by Piper Sandler to $31.00

0
97
Financial stock market investment trading graph. Candle stick graph chart. Currency exchange rates. Bullish point, Bearish point. trend on technology abstract background

Halozyme Therapeutics stock has undergone multiple analysts rating changes in the recent past.  Halozyme Therapeutics stock Target Raised by   Piper Sandler on 7/2/2020. In a note to investors, the firm issued a new target price of $31.00. The analysts previously had $28.00 target price. Piper Sandler’s price target would indicate a potential upside of 15.63% from the stock’s previous close.

Shares of Halozyme Therapeutics traded up $1.11 on Thursday, reaching $28.51. 2584672 shares of the stock traded hands, compared to its average volume of 1422362. Shares of Halozyme Therapeutics were trading at $28.51 on Thursday at close. The firm’s 50 day moving average is $$24.11 and its 200 day moving average is $19.53.Halozyme Therapeutics  has a 12 month low of $27.50 and a 12 month high of $28.97. While on yearly highs and lows, Halozyme Therapeutics today has traded high as $28.97 and has touched $27.50 on the downward trend.

Halozyme Therapeutics Earnings and What to expect: 

Halozyme Therapeutics last announced its quarterly earnings results on May 11th, 2020. The biopharmaceutical company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.02. The firm earned $25.30 million during the quarter, compared to analyst estimates of $42.96 million. Its revenue for the quarter was down 55.5% compared to the same quarter last year. Halozyme Therapeutics has generated ($0.50) earnings per share over the last year. Halozyme Therapeutics has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, August 4th, 2020 based off prior year’s report dates.

Latest Insiders Trading and Volume : 

  • Insider Ownership Percentage: 2.60%
  • On 5/20/2020 SVP Michael J Labarre Sell 21,387 at average share price of $23.80 which equates to $509,010.60 in money value.
  • On 3/19/2020 Director Kenneth J Kelley Buy 52,629 at average price of  $14.23 with total value of : Not Data Available
  • On 8/3/2019 SVP Dimitrios Chondros Sell 1,328 at average price of  $16.70 with total value of : $22,177.60
  • See More Analyst Rating at: RATING

Other Analyst’s rating for Halozyme Therapeutics

  • 7/2/2020 – Halozyme Therapeutics was upgraded by analysts at BidaskClub from a “buy” rating to a “strong-buy” rating. (View)
  • 7/1/2020 – Halozyme Therapeutics is now covered by analysts at Benchmark Co.. They set a “buy” rating and a $39.00 price target on the stock. (View)
  • 6/29/2020 – Halozyme Therapeutics had its “buy” rating re-affirmed by analysts at Piper Sandler. They now have a $28.00 price target on the stock. (View)
  • 6/15/2020 – Halozyme Therapeutics had its price target raised by analysts at Citigroup Inc from $18.00 to $26.00. They now have a “neutral” rating on the stock. (View)
  • See More Analyst Rating at: RATING

Other rating updates by Piper Sandler: 

  • 7/2/2020 – Brighthouse Financial had its price target lowered by analysts at Piper Sandler from $33.00 to $28.00. They now have a “neutral” rating on the stock. (View)
  • 7/2/2020 – CNO Financial Group had its price target raised by analysts at Piper Sandler from $14.00 to $15.00. They now have a “neutral” rating on the stock. (View)
  • 7/2/2020 – Globe Life had its price target lowered by analysts at Piper Sandler from $87.00 to $77.00. They now have a “neutral” rating on the stock. (View)
  • 7/2/2020 – Prudential Financial had its price target lowered by analysts at Piper Sandler from $67.00 to $63.00. They now have a “neutral” rating on the stock. (View)
  • See More Analyst Rating at: RATING

Halozyme Therapeutics (NASDAQ:HALO) Moving Average Technical Analysis

5 day Moving Average is $$26.66 And 5 day price change is $2.97 (11.63%)  with average volume for 5 day average is 2,126,980. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $24.68 and 20 day price change is $5.25 (22.57%) and average 20 day moving volume is 1,499,740. 50 day moving average is $24.11  and 50 day price change is $7.32 ( 34.54%)  and with average volume for 50 days is : 1,548,426. 200 day moving average is $19.53  and 200 day price change is $12.00 (72.68%)  and with average volume for 200 days is : 1,624,198.

See More Analyst Rating at: RATING